Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its latest quarterly report later this week. Analysts are predicting strong growth driven by the strong demand of https://nevemqgb670009.blogolenta.com/34504049/analyzing-eli-lilly-s-q3-results